Ampion Revenue and Competitors
Estimated Revenue & Valuation
- Ampion's estimated annual revenue is currently $24M per year.
- Ampion's estimated revenue per employee is $143,000
Employee Data
- Ampion has 168 Employees.
Ampion's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | SVP, Subscriber Acquisition | Reveal Email/Phone |
5 | VP, Human Capital | Reveal Email/Phone |
6 | VP, Law & Regulatory | Reveal Email/Phone |
7 | VP Account Management | Reveal Email/Phone |
8 | Director Sales | Reveal Email/Phone |
9 | IT Operations Director | Reveal Email/Phone |
10 | Director, Community Energy Acquisition and Strategy | Reveal Email/Phone |
Ampion Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $27.5M | 197 | 8% | $25.2M | N/A |
#2 | $8M | 68 | -16% | N/A | N/A |
#3 | $1.8M | 20 | 5% | N/A | N/A |
#4 | $2239.5M | 12305 | N/A | N/A | N/A |
#5 | $0.8M | 10 | -76% | N/A | N/A |
#6 | $1.1M | 14 | 0% | N/A | N/A |
#7 | $13.7M | 105 | -14% | $22.9M | N/A |
#8 | $3.8M | 37 | N/A | N/A | N/A |
#9 | $183M | 1035 | 4% | $323.2M | N/A |
#10 | $3.6M | 36 | -45% | $62.6M | N/A |
What Is Ampion?
Ampion empowers the clean energy revolution by bringing community energy programs to local communities. Through its software platform, Ampion connects residents, businesses, and other consumers with clean energy facilities that lower their electric costs without the need for installations or upfront costs.
keywords:N/A
N/A
Total Funding
168
Number of Employees
$24M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ampion News
Ampio said the U.S. Food and Drug Administration didn't agree that its recent Phase 3 study of Ampion--designed to evaluate pain and...
Ampion has been in development for several years, and many shareholders have remained loyal to the company throughout the ups and downs of that...
The company was evaluating Ampion in a phase 3 trial, dubbed AP-013, to treat pain due to osteoarthritis of the knee (OAK).
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.6M | 168 | 4% | $224.3M |
#2 | $27.1M | 168 | -20% | $106.9M |
#3 | $18.8M | 168 | -1% | N/A |
#4 | $41.9M | 168 | 6% | N/A |
#5 | $18.8M | 168 | 5% | N/A |